ITI-214 free base 是一种有效的中枢神经系统活性抑制剂,具有口服生物活性的 PDE1 抑制剂 (Ki of 58 pM),对其他PDE家族成员和一系列酶、受体、转运体和离子通道具有良好的选择性。ITI-214 free base 分别以 33 pM、380 pM和 35 pM 的 Ki 抑制重组人 PDE1A、PDE1B 和 PDE1C。ITI-214 free base 在各种运动和认知功能的动物模型中显示出有效性。
ITI214 (free base);ITI 214 free base;ITI-214 free base
Cas No.
1160521-50-5
分子式
C29H26FN7O
分子量
507.56
包装储存
Powder -20°C 3 years;4°C 2 years
详情描述
ITI-214 free base 是一种有效的中枢神经系统活性抑制剂,具有口服生物活性的 PDE1 抑制剂 (Ki of 58 pM),对其他PDE家族成员和一系列酶、受体、转运体和离子通道具有良好的选择性。ITI-214 free base 分别以 33 pM、380 pM和 35 pM 的 Ki 抑制重组人 PDE1A、PDE1B 和 PDE1C。ITI-214 free base 在各种运动和认知功能的动物模型中显示出有效性。
产品详情
ITI-214 free base 是一种有效的中枢神经系统活性抑制剂,具有口服生物活性的 PDE1 抑制剂 (Ki of 58 pM),对其他PDE家族成员和一系列酶、受体、转运体和离子通道具有良好的选择性。ITI-214 free base 分别以 33 pM、380 pM和 35 pM 的 Ki 抑制重组人 PDE1A、PDE1B 和 PDE1C。ITI-214 free base 在各种运动和认知功能的动物模型中显示出有效性。
生物活性
ITI-214 free base is a potent, CNS-active, orally bioavailable PDE1 inhibitor (K i of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 free base inhibits recombinant full-length human PDE1A, PDE1B and PDE1C with K i s of 33 pM, 380 pM and 35 pM, respectively. ITI-214 free base shows efficacy in various animal models of motor and cognitive functions.
性状
Solid
IC50 & Target[1][2]
PDE1 58 pM (Ki) PDE1A 33 pM (Ki)
体外研究(In Vitro)
ITI-214 is found to potently inhibit the activity of full-length recombinant r-hPDE1A (Ki=?34 pM), r-hPDE1B (Ki=?380 pM), and r-hPDE1C (Ki=?37 pM) enzymes transiently expressed in HEK cells. The compound expressed >1000-fold greater activity toward PDE1 isoforms compared with the next nearest PDE family enzyme, PDE4D (Ki=?33 nM) and 10,000-300,000-fold selectivity toward all other PDE enzyme families. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
ITI-214 significantly enhances memory performance in the test with a minimum effective dose of 3 mg/kg. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: Male Sprague-Dawley rats
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Li P, et al. Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases. J Med Chem. 2016 Feb 11;59(3):1149-64.[2]. Lawrence Wennogle. Novel uses. From PCT Int. Appl. (2014), WO 2014145617 A2 20140918.[3]. Peng Li , et al. Salt crystals
[1]. Li P, et al. Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases. J Med Chem. 2016 Feb 11;59(3):1149-64.[2]. Lawrence Wennogle. Novel uses. From PCT Int. Appl. (2014), WO 2014145617 A2 20140918.[3]. Peng Li , et al. Salt crystals